269 related articles for article (PubMed ID: 38566153)
21. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
[TBL] [Abstract][Full Text] [Related]
22. An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level.
Liu X; Gillis N; Jiang C; McCofie A; Shaw TI; Tan AC; Zhao B; Wan L; Duckett DR; Teng M
PLoS Comput Biol; 2024 Feb; 20(2):e1011873. PubMed ID: 38335222
[TBL] [Abstract][Full Text] [Related]
23. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status.
Vasileva AV; Gladkova MG; Ashniev GA; Osintseva ED; Orlov AV; Kravchuk EV; Boldyreva AV; Burenin AG; Nikitin PI; Orlova NN
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542080
[TBL] [Abstract][Full Text] [Related]
24. Mediator kinase inhibition further activates super-enhancer-associated genes in AML.
Pelish HE; Liau BB; Nitulescu II; Tangpeerachaikul A; Poss ZC; Da Silva DH; Caruso BT; Arefolov A; Fadeyi O; Christie AL; Du K; Banka D; Schneider EV; Jestel A; Zou G; Si C; Ebmeier CC; Bronson RT; Krivtsov AV; Myers AG; Kohl NE; Kung AL; Armstrong SA; Lemieux ME; Taatjes DJ; Shair MD
Nature; 2015 Oct; 526(7572):273-276. PubMed ID: 26416749
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
[TBL] [Abstract][Full Text] [Related]
26. The super-enhancer repertoire in porcine liver.
Zhang Y; Zhang J; Wang C; Dai H; Du X; Li Q; Pan Z
J Anim Sci; 2023 Jan; 101():. PubMed ID: 36800318
[TBL] [Abstract][Full Text] [Related]
27. Super-enhancers: Implications in gastric cancer.
Huang Y; Huo Y; Huang L; Zhang L; Zheng Y; Zhang N; Yang M
Mutat Res Rev Mutat Res; 2024; 793():108489. PubMed ID: 38355091
[TBL] [Abstract][Full Text] [Related]
28. Super-enhancer lncs to cardiovascular development and disease.
Ounzain S; Pedrazzini T
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1953-60. PubMed ID: 26620798
[TBL] [Abstract][Full Text] [Related]
29. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
30. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
31. Super-enhancers include classical enhancers and facilitators to fully activate gene expression.
Blayney JW; Francis H; Rampasekova A; Camellato B; Mitchell L; Stolper R; Cornell L; Babbs C; Boeke JD; Higgs DR; Kassouf M
Cell; 2023 Dec; 186(26):5826-5839.e18. PubMed ID: 38101409
[TBL] [Abstract][Full Text] [Related]
32. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
Gen Y; Muramatsu T; Inoue J; Inazawa J
Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
[TBL] [Abstract][Full Text] [Related]
33. Differentiated super-enhancers in lung cancer cells.
Li X; Lu C; Lu Q; Li C; Zhu J; Zhao T; Chen H; Jin H
Sci China Life Sci; 2019 Sep; 62(9):1218-1228. PubMed ID: 30635833
[TBL] [Abstract][Full Text] [Related]
34. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
[TBL] [Abstract][Full Text] [Related]
35. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
[TBL] [Abstract][Full Text] [Related]
36. Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges.
Kravchuk EV; Ashniev GA; Gladkova MG; Orlov AV; Vasileva AV; Boldyreva AV; Burenin AG; Skirda AM; Nikitin PI; Orlova NN
Cells; 2023 Apr; 12(8):. PubMed ID: 37190100
[TBL] [Abstract][Full Text] [Related]
37. Effects of BRD4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells.
Zheng J; Huang B; Xiao L; Wu M
PeerJ; 2024; 12():e17035. PubMed ID: 38410799
[TBL] [Abstract][Full Text] [Related]
38. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis.
Ounzain S; Micheletti R; Arnan C; Plaisance I; Cecchi D; Schroen B; Reverter F; Alexanian M; Gonzales C; Ng SY; Bussotti G; Pezzuto I; Notredame C; Heymans S; Guigó R; Johnson R; Pedrazzini T
J Mol Cell Cardiol; 2015 Dec; 89(Pt A):98-112. PubMed ID: 26423156
[TBL] [Abstract][Full Text] [Related]
39. TRlnc: a comprehensive database for human transcriptional regulatory information of lncRNAs.
Li Y; Li X; Yang Y; Li M; Qian F; Tang Z; Zhao J; Zhang J; Bai X; Jiang Y; Zhou J; Zhang Y; Zhou L; Xie J; Li E; Wang Q; Li C
Brief Bioinform; 2021 Mar; 22(2):1929-1939. PubMed ID: 32047897
[TBL] [Abstract][Full Text] [Related]
40. CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancer.
Yang Y; Jiang D; Zhou Z; Xiong H; Yang X; Peng G; Xia W; Wang S; Lei H; Zhao J; Qian Z; Wu S; Pang J
Cell Oncol (Dordr); 2021 Aug; 44(4):871-887. PubMed ID: 33905040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
